A Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for

Short title	A Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for
Status	Finished
Effective start/end date	1/10/08 → 31/03/14

Project Details